Loading…
This event has ended. Visit the official site or create your own event on Sched.
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Scientific Basis for Practice [clear filter]
Thursday, April 28
 

9:45am

Targeting the Needs of Unique Populations
  • "Adolescent and Young Adult Patient Survivorship Program: A Joint Effort Between a Cancer Institute and Community Organization," Alicia Coffin, RN, MSN, OCN®
  • "Neuroendocrine Tumors and Inherited Cancer Syndromes: Pheochromocytomas and Paragangliomas—Rare But Risky," Bonita Bennett, BSN, RN
  • "Taking it Head On: An Oncology Nurse-Led Team Approach to Decrease Treatment Delays and Hospitalizations in Head and Neck Cancer Patients," Helena Viveiros, RN, BSN, OCN®

Speakers
avatar for Alicia Maston Coffin, MS, RN, OCN

Alicia Maston Coffin, MS, RN, OCN

Nurse Manager / Survivorship Program Nurse Leader, University of Rochester / Wilmot Cancer Institute
HV

Helena Viveiros, RN, BSN, OCN®

RN, Steward St Anne's Regional Cancer Care
avatar for Bonita Bennett, BSN, RN

Bonita Bennett, BSN, RN

University of Pennsylvania



Thursday April 28, 2016 9:45am - 11:00am
304 200 E Market St, San Antonio, TX 78205

9:45am

American Association for Cancer Research/ONS Research Session: Epigenetics and Cancer

Epigenetic mechanisms control gene expression without changing the DNA sequence itself. Recent research progress has shown that epigenetic pathways may provide new therapeutic avenues in cancer. It is now apparent that changes in epigenetic control of gene expression in cancer cells, and surrounding cells in the tumor microenvironment, play a fundamental role in driving tumor development, as well as response to chemotherapy and immune treatment. Come to understand epigenetic effector pathways involved in tumor biology and new approaches to target these pathways in cancer treatment.

Objectives

  1. Understand epigenetic pathways in cancer.
  2. Discuss current research in the area of epigenetics in cancer.
  3. Describe how epigenetic pathways can be targeted for new cancer therapies.

Speakers
avatar for Peter Jones, PhD, DSc

Peter Jones, PhD, DSc

Research Director and Chief Scientific Officer, Van Andel Research Institute
avatar for Wendy Henderson, CRNP, MSN, PhD

Wendy Henderson, CRNP, MSN, PhD

Investigator & Chief Digestive Disorders Unit Biobehavioral Branch, Division of Intramural Research National Institute of Nursing Research National Institutes of Health Department of Health and Human Services


Thursday April 28, 2016 9:45am - 11:00am
221 200 E Market St, San Antonio, TX 78205

2:45pm

Immunology

Grasping the relationship between cancer and the immune system is complicated, but it is key to understanding the growing field of immunology and personalized medicine. Gain insight on how you can learn to help the body's immune system control cancer.


Speakers


Thursday April 28, 2016 2:45pm - 4:00pm
Stars at Night Ballroom 4 200 E Market St, San Antonio, TX 78205

2:45pm

Personalized Genomic Sequencing and the Future of Cancer Care: Discovery, Treatment, and Defeating the Disease*
Address the difference between genetics and genomics, the process of cancer genome sequencing, and how cancer sequencing can impact treatment to help you provide safe, effective care and education to patients and their families. You’ll also discuss the current and future impact of genomics on cancer care.

Sponsored by the Cancer Genetics Special Interest Group

*sSpecial interest group sessions are not part of the Congress evaluation. To earn your CNE, fill out the evaluation form given to you upon arrival to the SIG session and follow any directions provided by the session leader. Learn more about SIG Congress sessions.


This continuing nursing education activity was approved by the Oncology Nursing Society, an accredited approver by the American Nurses Credentialing Center’s COA.  

Speakers
avatar for Amy Tranin, APRN, AOCN®, RN-BC

Amy Tranin, APRN, AOCN®, RN-BC

Clinical Specialist, Oncology, NantHealth
I love my work and family. I love being an oncology nurse. I love to laugh!! Talk to me about what you love.


Thursday April 28, 2016 2:45pm - 4:00pm
217B 200 E Market St, San Antonio, TX 78205
 
Friday, April 29
 

12:15pm

Transforming Blood Cancer Care, the Role of Clinical Trials and CAR T-Cell Therapy
There has been great progress in treatment, but for most blood cancers, there is no cure and better therapies are needed. In this symposium, new and evolving treatment strategies will be discussed, including how the heterogeneous nature of blood cancers dictates treatment and prognosis, the role of clinical trials, and the evolving role of CAR T-cell therapy.  Cases will focus on acute myeloid leukemia (AML) and on diffuse large B-cell lymphoma (DLBCL). 

Sponsored by The Leukemia & Lymphoma Society and supported by educational grants from Kite Pharma, Inc. and Stemline Therapeutics, Inc.

Please click here to register for this event. 

Friday April 29, 2016 12:15pm - 1:45pm
Hemisfair Ballroom 200 E Market St, San Antonio, TX 78205

12:15pm

Working Group to Personalize Multidisciplinary Care in Patients with Lung Cancer: Updates and Evolving Concepts for Nurses
The Working Group to Personalize Multidisciplinary Care in Patients with Lung Cancer: Updates and Evolving Concepts for Nurses symposium features oncology nurses and physician peers discussing challenges in testing for epidermal growth factor receptor (EGFR) mutations, choosing an EGFR tyrosine kinase inhibitor (TKI), managing adverse events, addressing resistance to therapy, and the role of next-generation EGFR TKIs. Interactive case-based discussions will allow attendees to apply clinical evidence and expert opinion to patient care scenarios.

Co-Chairs 

 

Benjamin Levy, MD
Assistant Professor, Icahn School of Medicine
Medical Director, Thoracic Oncology Program, Mount Sinai Health Systems
Associate Director, Cancer Clinical Trials Office, Mount Sinai Hospital
Mount Sinai Hospital
New York, NY   

 

Karen Lee, MSN, FNP-BC
Mount Sinai Hospital
New York, NY 


Faculty 

 

Laura Brennan FNP-c, AOCNP
Division of Hematology & Oncology
UC Davis Medical Center
Sacramento, CA   

 

Ann Culkin, RN, OCN
Department of Nursing
Office Practice Nurse, Outpatient Thoracic Service
Memorial Sloan Kettering Cancer Center
New York, NY   

 

Alexander E. Drilon, MD
Thoracic Oncology Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY   

 

Jonathan Riess, MD, MS
Assistant Professor of Medicine
Division of Hematology Oncology
UC Davis Comprehensive Cancer Center
Sacramento, CA 


This activity is supported by educational grants from AstraZeneca. 

Please click here to register for this event. 

2:45pm

Immunotherapy: Nibs and Mabs

The development of new therapies aimed at the immune system to control cancer is exploding. It seems as if every day new drugs are being tested and released. Oncology APNs need to understand what these therapies are, how they work, and who should be receiving them. In this session, you’ll get the very latest information on monoclonal antibodies, cancer vaccines, immune checkpoint inhibitors, and more.


Speakers
avatar for Rowena Schwartz, PharmD, BCOP

Rowena Schwartz, PharmD, BCOP

‎VP, Clinical Content and Services, McKesson Specialty Health



2:45pm

Lessons in Symptom Science Research: A Conversation With the Experts

An expert panel of world-renowned nurse research scientists will explore the successes and challenges in symptom science. Discover the state of this research priority, including new models from NIH/NINR and implications for future research and practice. Join the discussion and get a glimpse of the future!

Objectives

  1. Describe what symptom science is and the application of the new symptom science model to research and practice.
  2. Analyze the successes and barriers to symptom science research and its impact on patient care.
  3. Discuss the future in symptom science implications for patient outcomes.

Moderators
avatar for Susan Beck, PhD, APRN, FAAN, AOCN®

Susan Beck, PhD, APRN, FAAN, AOCN®

Professor, University of Utah College of Nursing
Susan Larsen Beck, PhD, APRN, FAAN, AOCN is a professor at the University of Utah College of Nursing where she teaches in the doctoral program. With more than 30 years of experience as an advanced practice oncology nurse, Dr. Beck holds national credentials as an Advanced Oncology... Read More →

Speakers
avatar for Ruth McCorkle, PhD, RN, FAAN

Ruth McCorkle, PhD, RN, FAAN

Florence Wald Professor of Nursing, Yale University School of Nursing
are people still interested in your symptom distress scale?



Friday April 29, 2016 2:45pm - 4:00pm
221 200 E Market St, San Antonio, TX 78205

2:45pm

What's the Buzz? Tell Me What's Happening With Breast Cancer Screening*

Analysis of current data reveals a need for information related to care of women with different levels of risk of developing breast cancer. Gain the knowledge you need on breast cancer screening guidelines for women of average risk and learn about identification and medical management of breast cancer screening guidelines for women of high risk.

Sponsored by the Prevention/Early Detection Special Interest Group

*Special interest group sessions are not part of the Congress evaluation. To earn your CNE, fill out the evaluation form given to you upon arrival to the SIG session and follow any directions provided by the session leader. Learn more about SIG Congress sessions.

This continuing nursing education activity was approved by the Oncology Nursing Society, an accredited approver by the American Nurses Credentialing Center’s COA.  


Speakers
avatar for Sharon Byrne, DrNP, APN, NP-C, AOCNP®

Sharon Byrne, DrNP, APN, NP-C, AOCNP®

Nurse Practitioner, MD Anderson Cancer Center at Cooper
Sharon Byrne DrNP, CRNP, NP-C, AOCNP, CNE is an Advanced Practice Nurse at MD Anderson Cancer Center at Cooper, Division of Hematology/Oncology, Cooper Health System where she is a Nurse Practitioner for the Cancer Screening Project which is funded by NJCEED, Susan G. Komen for the... Read More →
avatar for Mary Vecchio, RN, MSN, ANP-C, OCN®

Mary Vecchio, RN, MSN, ANP-C, OCN®

Family Risk Assessment, Hunterdon Regional Cancer Center
Full disclosure: Nothing to disclose.


Friday April 29, 2016 2:45pm - 4:00pm
217B 200 E Market St, San Antonio, TX 78205